Greenwich LifeSciences
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 2,000 $13.11 $26,220
Purchase
THOMPSON JAYE officer: VP Clinical Reg Affairs
 Common Stock 250 $13.98 $3,495
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 1,000 $13.84 $13,840
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 2,000 $8.79 $17,580
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 3,000 $9.75 $29,250
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 2,000 $9.72 $19,440
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 1,000 $9.46 $9,460
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 1,000 $9.23 $9,230
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 6,465 $9.13 $59,025
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 22,535 $9.13 $205,745
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 8,000 $7.13 $57,040
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 12,000 $7.91 $94,920
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 12,000 $8.33 $99,960
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 4,500 $10.9 $49,050
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 6,000 $8.55 $51,300
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 9,250 $8.35 $77,238
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 6,774 $7.38 $49,992
Purchase
DAUGHERTY FRANK JOSEPH director, officer: Chief Medica..
 Common Stock 1,000 $16.25 $16,250
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 6,000 $16.09 $96,540
Purchase
THOMPSON JAYE officer: VP Clinical Reg Affairs
 Common Stock 500 $16.74 $8,370
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 6,000 $16.74 $100,440
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 5,500 $19.8 $108,900
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 5,000 $19.59 $97,950
Purchase
THOMPSON JAYE officer: VP Clinical Reg Affairs
 Common Stock 500 $18.47 $9,235
Purchase
HALLOCK KENNETH director
 Common Stock 300 $16.32 $4,896
Purchase
THOMPSON JAYE officer: VP Clinical Reg Affairs
 Common Stock 500 $16.33 $8,165
Purchase
THOMPSON JAYE officer: VP Clinical Reg. Affairs
 Common Stock 500 $18.87 $9,435
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 1,000 $19.99 $19,990
Purchase
DAUGHERTY FRANK JOSEPH director, officer: Chief Medica..
 Common Stock 1,000 $19.99 $19,990
Purchase
THOMPSON JAYE officer: VP Clinical Reg. Affairs
 Common Stock 1,000 $19.99 $19,990
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 2,050 $23.82 $48,831
Purchase
MCWILLIAMS DAVID director
 Common Stock 200 $27.56 $5,512
Purchase
PATEL SNEHAL director, 10 percent owner, off..
 Common Stock 1,840 $27.17 $49,993
Purchase
DAUGHERTY FRANK JOSEPH director, officer: Chief Medica..
 Common Stock 1,111 $26.99 $29,984
Purchase
PATEL SNEHAL director, officer: CEO and CFO
 Common Stock 2,700 $36.98 $99,854
Purchase
HALLOCK KENNETH director
 Common Stock 1,000 N/A N/A
Purchase
DAUGHERTY FRANK JOSEPH director, officer: Chief Medica..
 Common Stock 1,000 $5.1 $5,100
Purchase
MCWILLIAMS DAVID director
 Common Stock 1,500 N/A N/A
Purchase
HALLOCK KENNETH director
 Common Stock 1,000 N/A N/A
Purchase
ROTHE ERIC director
 Common Stock 2,000 N/A N/A
Purchase
PATEL SNEHAL director, officer: CEO and CFO
 Common Stock 2,000 $5.4 $10,796
Option
HALLOCK KENNETH director
 Common Stock 116,575 N/A N/A
Option
MCWILLIAMS DAVID director
 Common Stock 171,622 N/A N/A
Purchase
DAUGHERTY FRANK JOSEPH director, officer: Chief Medica..
 Common Stock 1,739 N/A N/A
Purchase
PATEL SNEHAL director, officer: CEO and CFO
 Common Stock 131,014 $5.18 $678,128
Option
MCWILLIAMS DAVID director
 Common Stock 171,622 N/A N/A
Option
MCWILLIAMS DAVID director
 Series A Preferred Stock 152,604 N/A N/A
Option
PATEL SNEHAL director, officer: CEO and CFO
 Common Stock 1,665,124 N/A N/A
Option
PATEL SNEHAL director, officer: CEO and CFO
 Series A Preferred Stock 176,448 N/A N/A
Option
PATEL KINNARY 10 percent owner
 Common Stock 129,400 N/A N/A

Showing 50 to 100 of 105 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: